| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 1997;63:180-185
© 1997 The Society of Thoracic Surgeons
Washington University School of Medicine, St. Louis, Missouri
Background. The identification, classification, and appropriate treatment of patients with pulmonary carcinomas demonstrating neuroendocrine differentiation remains controversial.
Methods. Patients undergoing resection of lung cancer at Washington University since 1986 were reviewed to identify all large cell neuroendocrine carcinomas. Cases were segregated into large, small, or mixed cell categories, and graded as moderate ("atypical carcinoid") or poorly differentiated (all higher grade lesions). All patients' charts were reviewed and referring physicians contacted to ascertain cancer treatment after resection and follow-up status.
Results. Forty patients were identified with large cell neuroendocrine carcinoma: 8 moderate and 32 high-grade. Average follow-up was 19.8 months. Stage distribution was as follows: I, 25; II, 6; III, 6; and VI, 3. Fifteen patients have no evidence of disease, 15 are dead of disease, and 6 are alive with disease. Five-year survival of the stage I patients is 18%; all-stage 5-year survival is 13%. Of the 15 patients who died of their disease, 80% had stage I or II disease. Postoperative chemotherapy, radiation therapy, or both were given to 9 of 26 patient in stage I, with six deaths (67%). Six of 17 patients (35%) with stage I disease died after no postoperative intervention.
Conclusions. Large cell neuroendocrine carcinomas identified by histologic examination have a remarkably poor prognosis even in very early stage disease. Adjuvant therapy did not improve survival.
This article has been cited by other articles:
|
|
 |
|
  C. A. Moran, S. Suster, D. Coppola, and M. R. Wick Neuroendocrine Carcinomas of the Lung: A Critical Analysis Am J Clin Pathol, February 1, 2009; 131(2): 206 - 221. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Iyoda, K. Hiroshima, Y. Nakatani, and T. Fujisawa Pulmonary Large Cell Neuroendocrine Carcinoma: Its Place in the Spectrum of Pulmonary Carcinoma Ann. Thorac. Surg., August 1, 2007; 84(2): 702 - 707. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Fujiwara, I. Sekine, K. Tsuta, Y. Ohe, H. Kunitoh, N. Yamamoto, H. Nokihara, K. Yamada, and T. Tamura Effect of Platinum Combined with Irinotecan or Paclitaxel against Large Cell Neuroendocrine Carcinoma of the Lung Jpn. J. Clin. Oncol., July 24, 2007; (2007) hym053v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. D. Kozower, R. Jarrett, S. Bhalla, and G. A. Patterson Clinical-pathologic conference in general thoracic surgery: Carinal resection for endobronchial grade I neuroendocrine carcinoma. J. Thorac. Cardiovasc. Surg., November 1, 2006; 132(5): 1219 - 1222. [Full Text] [PDF]
|
|
|
|
 |
|
 H. Asamura, T. Kameya, Y. Matsuno, M. Noguchi, H. Tada, Y. Ishikawa, T. Yokose, S.-X. Jiang, T. Inoue, K. Nakagawa, et al. Neuroendocrine Neoplasms of the Lung: A Prognostic Spectrum J. Clin. Oncol., January 1, 2006; 24(1): 70 - 76. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Chong, K. S. Lee, M. J. Chung, J. Han, O J. Kwon, and T. S. Kim Neuroendocrine Tumors of the Lung: Clinical, Pathologic, and Imaging Findings RadioGraphics, January 1, 2006; 26(1): 41 - 57. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Rossi, A. Cavazza, A. Marchioni, L. Longo, M. Migaldi, G. Sartori, N. Bigiani, L. Schirosi, C. Casali, U. Morandi, et al. Role of Chemotherapy and the Receptor Tyrosine Kinases KIT, PDGFR{alpha}, PDGFR{beta}, and Met in Large-Cell Neuroendocrine Carcinoma of the Lung J. Clin. Oncol., December 1, 2005; 23(34): 8774 - 8785. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Shin, S. M. Kang, Y. S. Kim, D. H. Shin, J. Chang, S. K. Kim, and S. K. Kim Identification of Tumor Suppressor Loci on the Long Arm of Chromosome 5 in Pulmonary Large Cell Neuroendocrine Carcinoma Chest, October 1, 2005; 128(4): 2999 - 3003. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Battafarano, F. G. Fernandez, J. Ritter, B. F. Meyers, T. J. Guthrie, J. D. Cooper, and G. A. Patterson Large cell neuroendocrine carcinoma: An aggressive form of non-small cell lung cancer J. Thorac. Cardiovasc. Surg., July 1, 2005; 130(1): 166 - 172. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. L. Filosso, E. Ruffini, A. Oliaro, O. Rena, C. Casadio, M. Mancuso, D. Turello, R. C. Cristofori, and G. Maggi Large-cell neuroendocrine carcinoma of the lung: A clinicopathologic study of eighteen cases and the efficacy of adjuvant treatment with octreotide J. Thorac. Cardiovasc. Surg., April 1, 2005; 129(4): 819 - 824. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Ab' Saber, L. M. Massoni Neto, C. P. Bianchi, B. B. Ctenas, E. R. Parra, E. M. Eher, J. C. Pereira, T. Takagaki, N. H. Yamaguchi, and V. L. Capelozzi Neuroendocrine and biologic features of primary tumors and tissue in pulmonary large cell carcinomas Ann. Thorac. Surg., June 1, 2004; 77(6): 1883 - 1890. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Iyoda, K. Hiroshima, Y. Moriya, T. Mizobuchi, M. Otsuji, Y. Sekine, K. Shibuya, T. Iizasa, Y. Saitoh, and T. Fujisawa Pulmonary large cell neuroendocrine carcinoma demonstrates high proliferative activity Ann. Thorac. Surg., June 1, 2004; 77(6): 1891 - 1895. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Paci, A. Cavazza, V. Annessi, I. Putrino, G. Ferrari, S. De Franco, and G. Sgarbi Large cell neuroendocrine carcinoma of the lung: a 10-year clinicopathologic retrospective study Ann. Thorac. Surg., April 1, 2004; 77(4): 1163 - 1167. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Casali, A. Stefani, G. Rossi, M. Migaldi, S. Bettelli, A. Parise, and U. Morandi The prognostic role of c-kit protein expression in resected large cell neuroendocrine carcinoma of the lung Ann. Thorac. Surg., January 1, 2004; 77(1): 247 - 252. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Oshiro, M. Kusumoto, Y. Matsuno, H. Asamura, R. Tsuchiya, H. Terasaki, H. Takei, A. Maeshima, S. Murayama, and N. Moriyama CT Findings of Surgically Resected Large Cell Neuroendocrine Carcinoma of the Lung in 38 Patients Am. J. Roentgenol., January 1, 2004; 182(1): 87 - 91. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Hage, K. Seldenrijk, P. de Bruin, H. van Swieten, and J. van den Bosch Pulmonary large-cell neuroendocrine carcinoma (LCNEC) Eur. J. Cardiothorac. Surg., April 1, 2003; 23(4): 457 - 460. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Zacharias, A. G. Nicholson, G. P. Ladas, and P. Goldstraw Large cell neuroendocrine carcinoma and large cell carcinomas with neuroendocrine morphology of the lung: prognosis after complete resection and systematic nodal dissection Ann. Thorac. Surg., February 1, 2003; 75(2): 348 - 352. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Iyoda, K. Hiroshima, M. Baba, Y. Saitoh, H. Ohwada, and T. Fujisawa Pulmonary large cell carcinomas with neuroendocrine features are high-grade neuroendocrine tumors Ann. Thorac. Surg., April 1, 2002; 73(4): 1049 - 1054. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Ginsberg Small cell lung cancer: how should we treat it? what is it? Ann. Thorac. Surg., November 1, 2000; 70(5): 1453 - 1454. [Full Text] [PDF]
|
|
|
|
|
|
M. Garcia-Yuste, J. M. Matilla, T. Alvarez-Gago, J. L. Duque, F. Heras, L. J. Cerezal, and G. Ramos Prognostic factors in neuroendocrine lung tumors: a Spanish multicenter study Ann. Thorac. Surg., July 1, 2000; 70(1): 258 - 263. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Wick and J. H. Ritter Neuroendocrine neoplasia of the lung Ann. Thorac. Surg., January 1, 2000; 69(1): 307 - 308. [Full Text] [PDF]
|
|
|
|
|
|
M. R. Wick and J. H. Ritter Thymic neuroendocrine tumors: : A commentary with current perspectives on neuroendocrine neoplasia Ann. Thorac. Surg., January 1, 1999; 67(1): 7 - 9. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
